The revolution of personalized pharmacotherapies for cystic fibrosis: what does the future hold?

CFTR modulators are benefiting many PwCF responsive to these drugs, yielding substantial improvements in various clinical outcomes. Meanwhile, the CF therapy development pipeline continues to expand with the development of novel CFTR modulators and alternative therapeutic strategies with the ultimate goal to provide effective therapies for all PwCF in the foreseeable future.